A Randomized, Double-blind, Placebo-controlled, Parallel Group, Exploratory Phase 2 Study of the Efficacy and Safety of Oral AMT-101 in Adults with Active Rheumatoid Arthritis who have demonstrated an inadequate Response to anti-TNF therapy
Latest Information Update: 12 Sep 2023
At a glance
- Drugs AMT 101 (Primary) ; Tumour necrosis factor alpha inhibitors
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms CASTRO
- Sponsors Applied Molecular Transport
- 02 May 2023 Status changed from recruiting to discontinued.
- 27 Mar 2023 According to an Applied Molecular Transport media release, after an extensive assessment of our clinical programs and the current business environment, the company have made the difficult decision to pause research and development as we close out existing programs and explore ending this trial at its current enrollment.
- 27 Mar 2023 According to an Applied Molecular Transport media release, the company's board of directors approved a workforce reduction of approximately 57% of its employee base and the engagement of MTS Health Partners, L.P. as advisors in a process to explore strategic alternatives for the company.